Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.
about
Comparison of echinocandin antifungalsECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patientsInvasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry.Successful treatment of liver aspergilloma by caspofungin acetate first-line therapy in a non-immunocompromised patient.A comparative evaluation of properties and clinical efficacy of the echinocandins.Caspofungin for treatment of invasive aspergillus infections.Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections.An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality.Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report.Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A.
P2860
Q28273738-0B6125F4-D44D-457A-BB46-6EDDB05B1CD1Q33573788-2B11A78D-DC36-4CAA-83D2-0C38C9C3AFD2Q33800526-A06B1653-70A0-4343-BB71-6895D86085C7Q35958060-DD3FFD32-2275-4C40-ABF6-A095FD6A7867Q36321765-831E0160-8292-42C1-9919-87BA867A4FADQ36895839-0CEC21E3-DE2C-45CE-AA61-CF6673552649Q37159584-B3620199-A44E-4730-8E46-42B657E5EC0BQ37863921-D11B39F5-ED9B-47C3-847E-42292D976391Q38871233-D5F2515D-57DC-45F0-8DBA-E4F5485EBB3FQ40399765-EB0F37D0-1607-4234-955D-B5D89425E455Q44664129-A04FFE2B-42EF-4763-850F-5E30D99CA0CBQ44952892-9F042A70-9F4C-4D26-BAEB-C899E5C8FAE6
P2860
Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Caspofungin as first line ther ...... with hematologic malignancies.
@en
Caspofungin as first line ther ...... with hematologic malignancies.
@nl
type
label
Caspofungin as first line ther ...... with hematologic malignancies.
@en
Caspofungin as first line ther ...... with hematologic malignancies.
@nl
prefLabel
Caspofungin as first line ther ...... with hematologic malignancies.
@en
Caspofungin as first line ther ...... with hematologic malignancies.
@nl
P2093
P2860
P1476
Caspofungin as first line ther ...... with hematologic malignancies
@en
P2093
Angela Michelutti
Anna Candoni
Federico Silvestri
Maurizio Castelli
Pierluigi Viale
Renato Fanin
Rosalba Mestroni
P2860
P304
P356
10.1111/J.1600-0609.2005.00500.X
P577
2005-09-01T00:00:00Z